SCHEMBL2803702

SCHEMBL2803702

[CH2]COc1ccc(OCCO)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.60
RECQL P46063 1/20 0.60
NR1I2 O75469 1/20 0.53
GAA P10253 1/20 0.50
CYP3A4 P08684 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
APP P05067 5/20 0.42
CA12 O43570 1/20 0.41
CA1 P00915 1/20 0.41
CA9 Q16790 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.40
ALOX5AP P20292 1/20 0.40
CYP19A1 P11511 1/20 0.39
PRSS1 P07477 1/20 0.39
MEN1 O00255 1/20 0.39
USP2 O75604 1/20 0.39
LMNA P02545 1/20 0.39
MAPK1 P28482 1/20 0.39
CASP1 P29466 1/20 0.39
KMT2A Q03164 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL48239 0.87 ALDH1A1 (0.75) ALDH1A1RECQLNR1I2GAACYP3A4
SCHEMBL28106819 0.87 ALDH1A1 (0.75) ALDH1A1RECQLNR1I2GAACYP3A4
Water SCHEMBL29229746 0.85 ALDH1A1 (0.71) ALDH1A1RECQLNR1I2GAACYP3A4
Ethylene Glycol SCHEMBL11119213 0.85 ALDH1A1 (0.71) ALDH1A1RECQLNR1I2GAACYP3A4
SCHEMBL152501 0.82 ALDH1A1 (0.68) ALDH1A1RECQLNR1I2GAACYP3A4
SCHEMBL2720663 0.82 ALDH1A1 (0.68) ALDH1A1RECQLNR1I2GAACYP3A4
SCHEMBL9119081 0.82 ALDH1A1 (0.68) ALDH1A1RECQLNR1I2GAACYP3A4
SCHEMBL14004241 0.82 ALDH1A1 (0.68) ALDH1A1RECQLNR1I2GAACYP3A4
SCHEMBL14151809 0.82 ALDH1A1 (0.56) ALDH1A1RECQLNR1I2GAACYP3A4
SCHEMBL4707838 0.82 NQO1 (0.47) GAASMN1; SMN2APPCA12CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8222277-B2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use NICOX S.A. (FR) 2012-07-17 US disclosed
US-7754772-B2 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use NICOX, S.A. (FR) 2010-07-13 US disclosed
EP-1539729-A4 NITROSATED NONSTEROIDAL ANTIINFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE NITROMED INC (US) 2008-02-20 EP disclosed
US-20050222243-A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use NITROMED, INC. (US) 2005-10-06 US disclosed
EP-1539729-A2 NITROSATED NONSTEROIDAL ANTIINFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE Nitromed, Inc. (US) 2005-06-15 EP disclosed
US-20040024057-A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use related applications NITROMED, INC. 2004-02-05 US disclosed
WO-2004004648-A2 NITROSATED NONSTEROIDAL ANTIINFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE NITROMED, INC. (US) 2004-01-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040024057-A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use related applications NOS2, NOS1, NOS3 ALDH1A1 383/4885RECQL 1442/4885NR1I2 523/4885
US-20050222243-A1 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use NOS2, NOS1, NOS3 ALDH1A1 385/4885RECQL 1384/4885NR1I2 438/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.